Compare ADMA Biologics Inc (ADMA) vs Blackstone Inc (BX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Blackstone Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Blackstone Inc trades at $147.89 (market cap $117.44B). The key difference: Blackstone Inc is far larger — about 52.9× ADMA Biologics Inc's market cap, and Blackstone Inc pays a 3.55% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | BX | |
|---|---|---|
Market Cap | $2.22B | $117.44B |
Sector | Health | Financials |
52-Week High | $20.38 | $188.68 |
52-Week Low | $7.60 | $102.12 |
Enterprise Value | $2.29B | — |
Dividend Yield | — | 3.55% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Blackstone Inc
Blackstone is one of the world's largest alternative asset managers with $940.8 billion in total asset under management, including $683.8 billion in fee-earning asset under management, at the end of June 2022.
Read more on BX →
